MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1

Journal of Biomedical Science

Volumn 20, Issue 1, 2013, Pages

  Zhang, Chun Mei ^a   Zhao, Jing ^a   Deng, Hua Yu ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

MCF 7 breast cancer cells; MiR 155; Proliferation; TP53INP1 (tumor protein 53 induced nuclear protein 1)

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; ESTROGEN RECEPTOR ALPHA; LUCIFERASE; MESSENGER RNA; MICRORNA 155; NUCLEAR PROTEIN; PROTEIN P21; PROTEIN P53; TUMOR PROTEIN 53 INDUCED NUCLEAR PROTEIN 1; UNCLASSIFIED DRUG; CARRIER PROTEIN; CASPASE; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; ESTROGEN RECEPTOR; HEAT SHOCK PROTEIN; MICRORNA; MIRN155 MICRORNA, HUMAN; TP53INP1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; WESTERN BLOTTING; BREAST TUMOR; CELL CYCLE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MCF 7 CELL LINE; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION;

APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CARRIER PROTEINS; CASPASES; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HUMANS; MCF-7 CELLS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN;

EID: 84886055056     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-20-79     Document Type: Article

References (34)

1. Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells. Yu X, Zhang X, Dhakal IB, Beggs M, Kadlubar S, Luo D, BMC cancer 2012 12 29 10.1186/1471-2407-12-29 22260523
2. Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Bhat-Nakshatri P, Wang G, Collins NR, Thomson MJ, Geistlinger TR, Carroll JS, Brown M, Hammond S, Srour EF, Liu Y, Nakshatri H, Nucleic acids research 2009 37 14 4850 4861 10.1093/nar/gkp500 19528081
3. Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Wickramasinghe NS, Manavalan TT, Dougherty SM, Riggs KA, Li Y, Klinge CM, Nucleic acids research 2009 37 8 2584 2595 10.1093/nar/gkp117 19264808
4. Estradiol-activated estrogen receptor alpha does not regulate mature microRNAs in T47D breast cancer cells. Katchy A, Edvardsson K, Aydogdu E, Williams C, The Journal of steroid biochemistry and molecular biology 2012 128 3-5 145 153 22079223
5. MicroRNAs: target recognition and regulatory functions. Bartel DP, Cell 2009 136 2 215 233 10.1016/j.cell.2009.01.002 19167326
6. A developmental view of microRNA function. Zhao Y, Srivastava D, Trends in biochemical sciences 2007 32 4 189 197 10.1016/j.tibs.2007.02.006 17350266 (Pubitemid 46603281)
7. MicroRNAs and cancer: short RNAs go a long way. Ventura A, Jacks T, Cell 2009 136 4 586 591 10.1016/j.cell.2009.02.005 19239879
8. Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA. Tam W, Gene 2001 274 1-2 157 167 11675008 (Pubitemid 32817133)
9. Imaging individual microRNAs in single mammalian cells in situ. Lu J, Tsourkas A, Nucleic acids research 2009 37 14 100 10.1093/nar/gkp482 19515934
10. MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. Kong W, He L, Coppola M, Guo J, Esposito NN, Coppola D, Cheng JQ, The Journal of biological chemistry 2010 285 23 17869 17879 10.1074/jbc.M110.101055 20371610
11. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Jiang S, Zhang HW, Lu MH, He XH, Li Y, Gu H, Liu MF, Wang ED, Cancer research 2010 70 8 3119 3127 10.1158/0008-5472. CAN-09-4250 20354188
12. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Kong W, Yang H, He L, Zhao JJ, Coppola D, Dalton WS, Cheng JQ, Molecular and cellular biology 2008 28 22 6773 6784 10.1128/MCB.00941-08 18794355
13. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC, Cancer cell 2006 9 3 189 198 10.1016/j.ccr.2006.01.025 16530703 (Pubitemid 43357945)
14. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer DG, Cancer research 2009 69 14 5776 5783 10.1158/0008-5472.CAN-09-0587 19584273
15. MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE, The Journal of clinical endocrinology and metabolism 2008 93 5 1600 1608 10.1210/jc.2007-2696 18270258 (Pubitemid 351656494)
16. Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma. Ryu JK, Hong SM, Karikari CA, Hruban RH, Goggins MG, Maitra A, Pancreatology 2010 10 1 66 73 10.1159/000231984 20332664
17. MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Habbe N, Koorstra JB, Mendell JT, Offerhaus GJ, Ryu JK, Feldmann G, Mullendore ME, Goggins MG, Hong SM, Maitra A, Cancer biology & therapy 2009 8 4 340 346 10.4161/cbt.8.4.7338 19106647
18. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J, Garcia S, Nowak J, Yeung ML, Jeang KT, Chaix A, Fazli L, Motoo Y, Wang Q, Rocchi P, Russo A, Gleave M, Dagorn JC, Iovanna JL, Carrier A, Pebusque MJ, Dusetti NJ, Proc Natl Acad Sci U S A 2007 104 41 16170 16175 10.1073/pnas.0703942104 17911264 (Pubitemid 350099380)
19. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Greither T, Grochola LF, Udelnow A, Lautenschlager C, Wurl P, Taubert H, International journal of cancer. Journal international du cancer 2010 126 1 73 80 10.1002/ijc.24687 19551852
20. Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas. Pedersen IM, Otero D, Kao E, Miletic AV, Hother C, Ralfkiaer E, Rickert RC, Gronbaek K, David M, EMBO molecular medicine 2009 1 5 288 295 10.1002/emmm.200900028 19890474
21. Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. Costinean S, Sandhu SK, Pedersen IM, Tili E, Trotta R, Perrotti D, Ciarlariello D, Neviani P, Harb J, Kauffman LR, Shidham A, Croce CM, Blood 2009 114 7 1374 1382 10.1182/blood-2009-05-220814 19520806
22. Circulating microRNAs in breast cancer and healthy subjects. Zhu W, Qin W, Atasoy U, Sauter ER, BMC research notes 2009 2 89 10.1186/1756-0500-2-89 19454029
23. Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function. Cano CE, Gommeaux J, Pietri S, Culcasi M, Garcia S, Seux M, Barelier S, Vasseur S, Spoto RP, Pebusque MJ, Dusetti NJ, Iovanna JL, Carrier A, Cancer research 2009 69 1 219 226 10.1158/0008-5472.CAN-08-2320 19118006
24. Molecular and functional characterization of the stress-induced protein (SIP) gene and its two transcripts generated by alternative splicing SIP induced by stress and promotes cell death. Tomasini R, Samir AA, Vaccaro MI, Pebusque MJ, Dagorn JC, Iovanna JL, Dusetti NJ, The Journal of biological chemistry 2001 276 47 44185 44192 10.1074/jbc.M105647200 11557757
25. P53-dependent expression of the stress-induced protein (SIP). Tomasini R, Samir AA, Pebusque MJ, Calvo EL, Totaro S, Dagorn JC, Dusetti NJ, Iovanna JL, European journal of cell biology 2002 81 5 294 301 10.1078/0171-9335-00248 12067065 (Pubitemid 34568210)
26. Assignment of tumor protein p53 induced nuclear protein 1 (TP53INP1) gene to human chromosome band 8q22 by in situ hybridization. Nowak J, Tomasini R, Mattei MG, Azizi Samir LA, Dagorn JC, Dusetti N, Iovanna JL, Pebusque MJ, Cytogenetic and genome research 2002 97 1-2 140E 12438758
27. TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity. Tomasini R, Samir AA, Carrier A, Isnardon D, Cecchinelli B, Soddu S, Malissen B, Dagorn JC, Iovanna JL, Dusetti NJ, The Journal of biological chemistry 2003 278 39 37722 37729 10.1074/jbc.M301979200 12851404 (Pubitemid 37175297)
28. p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Okamura S, Arakawa H, Tanaka T, Nakanishi H, Ng CC, Taya Y, Monden M, Nakamura Y, Molecular cell 2001 8 1 85 94 10.1016/S1097-2765(01)00284-2 11511362 (Pubitemid 32772907)
29. Decreased expression of tumor protein p53-induced nuclear protein 1 (TP53INP1) in breast carcinoma. Ito Y, Motoo Y, Yoshida H, Iovanna JL, Takamura Y, Miya A, Kuma K, Miyauchi A, Anticancer research 2006 26 6B 4391 4395 17201159 (Pubitemid 46031512)
30. Down-expression of tumor protein p53-induced nuclear protein 1 in human gastric cancer. Jiang PH, Motoo Y, Garcia S, Iovanna JL, Pebusque MJ, Sawabu N, World journal of gastroenterology: WJG 2006 12 5 691 696 16521180 (Pubitemid 43380749)
31. MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo. Jiang F, Liu T, He Y, Yan Q, Chen X, Wang H, Wan X, BMC cancer 2011 11 425 10.1186/1471-2407-11-425 21970405
32. Apoptosis in cancer: from pathogenesis to treatment. Wong RS, Journal of experimental & clinical cancer research: CR 2011 30 87 10.1186/1756-9966-30- 87 21943236
33. Heterotrimeric G proteins and apoptosis: intersecting signaling pathways leading to context dependent phenotypes. Yanamadala V, Negoro H, Denker BM, Current molecular medicine 2009 9 5 527 545 10.2174/156652409788488784 19601805
34. Executioner caspase-3 and caspase-7 are functionally distinct proteases. Walsh JG, Cullen SP, Sheridan C, Luthi AU, Gerner C, Martin SJ, Proc Natl Acad Sci U S A 2008 105 35 12815 12819 10.1073/pnas.0707715105 18723680